LISA, Francesco

LISA, Francesco  

SCIENZE MEDICHE  

Mostra records
Risultati 1 - 20 di 32 (tempo di esecuzione: 0.038 secondi).
Titolo Data di pubblicazione Autore(i) File
[Cutaneous melanoma at the Turin Melanoma Center. I. Survival and correlation with clinical and histologic prognostic factors in 502 patients in stage I (1975-1985)] 1986 BERNENGO MG ;DOVEIL GC ;LISA F ;PIPPIONE M ;ALOI FG ;STUARDI C ;ZINA G
[Cutaneous melanoma at the Turin Melanoma Center. II. Risk of metastasis and free interval in relation to the clinical and histological prognostic factors in 502 patients in stage I (1975-1985)] 1987 BERNENGO MG ;DOVEIL GC ;LISA F ;STUARDI C ;ZINA G
ALK expression favorably impacts the prognosis of NRAS-mutated metastatic melanomas 2018 Osella-Abate, Simona; Mereu, Elisabetta; Pellegrino, Elisa; Bergaggio, Elisa; Ribero, Simone; Bertero, Luca; Lisa, Francesco; Fierro, Maria Teresa; Papotti, Mauro Giulio; Piva, Roberto*
BANS: a discussion of the problem. 1992 BERNENGO MG ;REALI UM ;DOVEIL GC ;CAPPELLO N ;LISA F ;MORETTI S
Biological prognostic factors in advanced metastatic melanoma patients treated with chemoimmunotheraphy. 1997 Fierro MT; Quaglino P; Lisa F; Savoia P; Bernengo MG
Blood Flow Cytometry in Sézary Syndrome: New Insights on Prognostic Relevance and Immunophenotypic Changes During Follow-up. 2015 Novelli M; Fava P; Sarda C; Ponti R; Osella-Abate S; Savoia P; Bergallo M; Lisa F; Fierro MT; Quaglino P.
Changes in T and B lymphocyte subpopulations before, during and after chemotherapy for malignant melanoma. 1984 BERNENGO MG ;LISA F ;MEREGALLI M ;DOVEIL GC
Clinical presentation and immunological features of an Italian ATL case 1995 FIERRO MT; SAVOIA P; NOVELLI M; GHISETTI V; LISA F; BERNENGO MG
Collagenase digestion and mechanical disaggregation as a method to extract and immunophenotype tumour lymphocytes in cutaneous T-cell lymphomas. 2000 M. NOVELLI; SAVOIA P; CAMBIERI I; PONTI R; COMESSATTI A; LISA F; BERNENGO MG
Flow cytometry immunophenotyping in mycosis fungoides 2008 Novelli M; Fierro MT; Quaglino P; Comessatti A; Lisa F; Ponti R; Savoia P; Bernengo MG.
Functional properties in Sézary cells with an unusual phenotype. 1985 BERNENGO MG ;MEREGALLI M ;JEMMA C ;LISA F
In vitro and in vivo effect of thymostimulin in melanoma patients. 1984 BERNENGO MG; LISA F; FRA P; MEREGALLI M; NOVELLI M; ZINA G.
KM-93 expression on peripheral blood lymphocytes (PBL) in inflammatory skin diseases, mycosis fungoides and Sézary syndrome. 1995 Quaglino P; Fierro MT; Savoia P; Novelli M; Lisa F; Bernengo MG
Low-dose intermittent Alemtuzumab in Sézary Syndrome: clinical activity, toxicity profile and immunological findings in 17 patients. 2008 Bernengo MG; Quaglino P; Comessatti A; Ortoncelli M; Novelli M; Lisa F; Fierro MT
Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients. 2007 BERNENGO MG; QUAGLINO P; COMESSATTI A; ORTONCELLI M; NOVELLI M; LISA F; FIERRO MT
Macrophage-mediated antitumor immunostimulation or immunosuppression modulates IL-2 therapeutic efficacy in advanced metastatic melanoma (MM) patients. 1997 Quaglino P; Lisa F; Cappello N; Zaccagna A; Bernengo MG.
Macrophage-mediated immunostimulation modulates therapeutic efficacy of interleukin-2 based chemoimmunotherapy in advanced metastatic melanoma patients. 2000 M. BERNENGO; QUAGLINO P; CAPPELLO N; LISA F; OSELLA-ABATE S; FIERRO MT
PAS expression is related to survival in Sézary syndrome patients 2008 Novelli Mauro; La Selva Roberta; Quaglino Pietro; Ponti Renata; Comessatti Alessandra; De Matteis Antonietta; Titli Stefano; Lisa Francesco; Fierro Maria Teresa; Bernengo Maria Grazia
Peripheral blood involvement in a mycosis fungoides patient with limited skin lesions: phenotypical features and homing molecule pattern 2001 P. QUAGLINO; S. OSELLA-ABATE; M. NOVELLI; F. LISA; A. COMESSATTI; M.G. BERNENGO
Prognostic factors in Sezary sindrome 1997 Bernengo MG; Quaglino P; Novelli M; Cappello N; Doveil GC; Lisa F; De Matteis A; Fierro MT; Appino A.